Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

VCNX Stock Annual Income Statement. Download in Excel

Vaccinex Inc. logo

Vaccinex Inc.

Sector: Healthcare   

Industry: Biotechnology

3.60
 
USD
  
-0.11
  
(-2.96%)
Previous close: 3.71  Open: 3.7  Bid: 3.36  Ask: 3.6
52 week range    
1.39   
   13.02
Mkt Cap: 8 M  Avg Vol (90 Days): 95,551
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 22nd November 2024

Stock Rankings

49
MarketXLS Rank
60
Value
46
Technical
42
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

VCNX Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-23.1-163.8-98.7-43.68
Basic EPS total-23.1-163.8-98.7-43.68
Basic weighted shares outstanding5 M858716.01 M137377.0202082.0463653.0
Cost of sales-1 M199000.02000.0
Depreciation-223000.0-249000.0307000.0169000.0207000.0119000.0
DepreciationAndAmortization-223000.0-249000.0307000.0169000.0207000.0119000.0
Diluted EPS total-5.65-37.05-23.1-163.8-98.7-43.68
Diluted normalized net income/share-37.05-98.7-43.68
Diluted weighted shares outstanding5 M858716.01 M137377.0202082.0463653.0
GeneralAndAdministrativeExpense5 M7 M7 M6 M6 M7 M
Gross operating profit-309000.0324000.0623000.0900000.0275000.0570000.0
Income before tax-30 M-32 M-29 M-22 M-20 M-20 M
Interest income369000.0
InterestExpenseNonOperating392000.0489000.0809000.02000.01000.0
MinorityInterests12 M-3 M7 M
MiscOtherSpecialCharges-2 M152000.0-31000.043000.093000.0-1 M
Net income from total operations-30 M-32 M-29 M-23 M-20 M-20 M
NetIncomeCommonStockholders-30 M-32 M-29 M-22 M-20 M-20 M
NetIncomeContinuousOperations-30 M-32 M-29 M-23 M-20 M-20 M
NetNonOperatingInterestIncomeExpense-23000.0-489000.0-809000.0-2000.0-1000.0
Normalized income-18 M-16 M
Operating income-27 M-32 M-28 M-22 M-20 M-23 M
Operating income before depreciation (EBITDA)-29 M-32 M-28 M-21 M-20 M-20 M
OperatingExpense27 M32 M29 M23 M20 M23 M
Other income net2 M-152000.031000.0-43000.0-93000.03 M
OtherGandA5 M7 M7 M6 M6 M7 M
OtherOperatingExpenses175000.0181000.0
RentAndLandingFees5 M-168000.0169000.0174000.0175000.0
Research & development expense22 M26 M22 M17 M14 M17 M
ResearchExpense22 M26 M22 M17 M14 M17 M
SalariesAndWages-177000.0-447000.0-575000.0
Selling Gen & administrative expense5 M7 M7 M6 M6 M7 M
Total Income available for interest expense (EBIT)-29 M-32 M-28 M-22 M-20 M-20 M
Total common shares outstanding11 M1 M2 M203162.0237527.0
Total net income-30 M-32 M-29 M-23 M-20 M-20 M
Total ordinary shares2 M2 M2 M2 M2 M2 M
Total revenues724000.0523000.0625000.0900000.0275000.0570000.0
TotalExpenses26 M33 M29 M23 M20 M23 M
TotalRevenue724000.0523000.0625000.0900000.0275000.0570000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University